Irena Adkins

Irena Adkins

Company: SOTIO

Job title: Director - Pharmacology


SOT201 is a novel targeted IL-15RBy agonist to alleviate PD-1- mediated immune cell suppression and potentiate anti-tumor efficacy 1:00 pm

SOT201 is a novel immunocytokine consisting of a monoclonal humanized, Fc silenced antibody against PD-1 fused to a covalent RLI-15 complex of a human IL-15 mutein linked to the high-affinity binding site of the IL-15R, the sushi+ domain developed for immunotherapeutic treatment of various types of cancers. The activity of SOT201 is based on spatiotemporal…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.